68 Ga-DOTA-TFpep Targeting the Thomsen–Friedenreich Antigen for PET Imaging
Molecular Pharmaceutics · 2026
DOI: 10.1021/acs.molpharmaceut.5c01313 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Nianting Ju und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, Chi…. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Gallium Radioisotopes, Radiopharmaceuticals, Antigens, Tumor-Associated, Carbohydrate. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, China Postdoctoral Science Foundation, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
As an important tumor-associated carbohydrate antigen, the Thomsen-Friedenreich (T or TF) antigen has become an attractive target for tumor diagnosis and treatment. However, there has been very limited success in developing peptide- and small-molecule-based radiopharmaceuticals for this important target. Currently, only 64Cu-NO2A-TFpep has been reported as a radiolabeled peptide targeting the TF antigen, and it shows a low tumor-to-liver ratio due to 64Cu retention in the liver. In this study, a novel PET probe targeting the TF antigen (DOTA-TFpep) was synthesized using 2,2',2″,2‴-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic acid (DOTA) chelator for increasing the hydrophilic property and for radiolabeling with different radionuclides. DOTA-TFpep was then radiolabeled with 68Ga for positron emission tomography (PET) imaging of breast tumors expressing the TF antigen. 68Ga-DOTA-TFpep was confirmed by radio-HPLC with a purity greater than 98% and high stability in PBS. Immunofluorescence analysis confirmed the TF antigen expression of 4T1 and K1 cell lines. Cell uptake studies confirmed its targeting specificity. Further in vivo biodistribution studies in high (4T1) and low (K1) TF antigen-expression xenograft models demonstrated the favorable pharmacokinetics property of the probe. PET imaging and biodistribution showed that 68Ga-DOTA-TFpep exhibited specific tumor uptake. Moreover, compared with the widely studied 64Cu-NO2A-TFpep, 68Ga-DOTA-TFpep showed lower liver uptake and a higher tumor-to-liver ratio (1.31 ± 0.20 for 64Cu-NO2A-TFpep and 0.48 ± 0.15 for 68Ga-DOTA-TFpep at 120 min after injection). In summary, this study demonstrates the synthesis and evaluation of the TF antigen-targeting probe 68Ga-DOTA-TFpep. It shows favorable in vivo tumor imaging properties, highlighting it as a promising molecular probe targeting the TF antigen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
- State Key Laboratory of Drug Research, Molecular Imaging Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- School of Biomedical Engineering and School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
- School of Pharmacy, University of Chinese Academy of Sciences, No.19A Yuquan Road, Beijing 100049, China.
- Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong 264117, China.
ORCID-Profile: Nianting Ju, Zhen Cheng
Förderung
- Natural Science Foundation of Shanghai Municipality
- China Postdoctoral Science Foundation
- Science and Technology Commission of Shanghai Municipality
- Ningbo Major Research and Development Plan Project
- Shandong Laboratory Program
- Shanghai Post-doctoral Excellence Program
Zitieren
APA
Ju, N., Tan, B., Lou, H., Zhang, Y., Qian, K., Qu, C., Luo, Q., & Cheng, Z. (2026). 68 Ga-DOTA-TFpep Targeting the Thomsen–Friedenreich Antigen for PET Imaging. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01313
Vancouver
Ju N, Tan B, Lou H, Zhang Y, Qian K, Qu C, et al. 68 Ga-DOTA-TFpep Targeting the Thomsen–Friedenreich Antigen for PET Imaging. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01313
BibTeX
@article{Ju2026,
author = {Ju, Nianting and Tan, Boyu and Lou, Hongyue and Zhang, Ying and Qian, Kun and Qu, Chunrong and Luo, Quanyong and Cheng, Zhen},
title = {68 Ga-DOTA-TFpep Targeting the Thomsen–Friedenreich Antigen for PET Imaging},
journal = {Molecular Pharmaceutics},
year = {2026},
doi = {10.1021/acs.molpharmaceut.5c01313}
}
EUVIMED